These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36512307)

  • 41. Targeted therapy of chronic myeloid leukemia.
    Sullivan C; Peng C; Chen Y; Li D; Li S
    Biochem Pharmacol; 2010 Sep; 80(5):584-91. PubMed ID: 20470758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro.
    Liu MY; Wang WZ; Liao FF; Wu QQ; Lin XH; Chen YH; Cheng L; Jin XB; Zhu JY
    Cell Biol Int; 2017 Jan; 41(1):16-23. PubMed ID: 27677634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
    Toda J; Ichii M; Oritani K; Shibayama H; Tanimura A; Saito H; Yokota T; Motooka D; Okuzaki D; Kitai Y; Muromoto R; Kashiwakura JI; Matsuda T; Hosen N; Kanakura Y
    Oncogene; 2020 Aug; 39(34):5601-5615. PubMed ID: 32661325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia.
    Vuelta E; Ordoñez JL; Alonso-Pérez V; Méndez L; Hernández-Carabias P; Saldaña R; Sevilla J; Sebastián E; Muntión S; Sánchez-Guijo F; Hernández-Rivas JM; García-Tuñón I; Sánchez-Martín M
    CRISPR J; 2021 Aug; 4(4):519-535. PubMed ID: 34406033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia.
    Finch ER; Kudva AK; Quickel MD; Goodfield LL; Kennett MJ; Whelan J; Paulson RF; Prabhu KS
    Cancer Prev Res (Phila); 2015 Oct; 8(10):989-99. PubMed ID: 26290393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells.
    Tanaka Y; Fukushima T; Mikami K; Adachi K; Fukuyama T; Goyama S; Kitamura T
    Exp Hematol; 2020 Oct; 90():46-51.e2. PubMed ID: 32910995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.
    Zhang X; Ren R
    Blood; 1998 Nov; 92(10):3829-40. PubMed ID: 9808576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.
    Lernoux M; Schnekenburger M; Losson H; Vermeulen K; Hahn H; Gérard D; Lee JY; Mazumder A; Ahamed M; Christov C; Kim DW; Dicato M; Bormans G; Han BW; Diederich M
    Clin Epigenetics; 2020 May; 12(1):69. PubMed ID: 32430012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
    Babashah S; Sadeghizadeh M; Hajifathali A; Tavirani MR; Zomorod MS; Ghadiani M; Soleimani M
    Int J Cancer; 2013 Aug; 133(3):579-89. PubMed ID: 23341351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic myelogenous leukemia: molecular and cellular aspects.
    Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
    J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival.
    Ishiura M; Kitai Y; Kashiwakura JI; Muromoto R; Toda J; Ichii M; Oritani K; Matsuda T
    Biochem Biophys Res Commun; 2021 Jun; 556():185-191. PubMed ID: 33845308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells.
    Zhang H; Peng C; Hu Y; Li H; Sheng Z; Chen Y; Sullivan C; Cerny J; Hutchinson L; Higgins A; Miron P; Zhang X; Brehm MA; Li D; Green MR; Li S
    Nat Genet; 2012 Jul; 44(8):861-71. PubMed ID: 22797726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
    Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
    Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.
    Chen Y; Peng C; Abraham SA; Shan Y; Guo Z; Desouza N; Cheloni G; Li D; Holyoake TL; Li S
    J Clin Invest; 2014 Sep; 124(9):3847-62. PubMed ID: 25105362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.
    Yang S; Zhu XN; Zhang HL; Yang Q; Wei YS; Zhu D; Liu MD; Shen SM; Xia L; He P; Ge MK; Pan YL; Zhao M; Wu YL; Zheng JK; Chen GQ; Yu Y
    Blood; 2021 Dec; 138(24):2485-2498. PubMed ID: 34359074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple gene knockdown strategies for investigating the properties of human leukemia stem cells and exploring new therapies.
    Wu A; Ansari AS; Uludaǧ H; Jiang X
    Methods Cell Biol; 2022; 171():1-22. PubMed ID: 35953195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
    Peng C; Li S
    Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.
    Prost S; Relouzat F; Spentchian M; Ouzegdouh Y; Saliba J; Massonnet G; Beressi JP; Verhoeyen E; Raggueneau V; Maneglier B; Castaigne S; Chomienne C; Chrétien S; Rousselot P; Leboulch P
    Nature; 2015 Sep; 525(7569):380-3. PubMed ID: 26331539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia.
    Sharma P; Sachdeva MUS; Naseem S; Sreedharanunni S; Das R; Malhotra P; Varma N
    Int J Lab Hematol; 2022 Jun; 44(3):518-523. PubMed ID: 35142061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.